Shopping Cart 0
Cart Subtotal
USD 0

TearLab Corp (TEAR) - Product Pipeline Analysis, 2018 Update

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 750

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 1500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 2250
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

TearLab Corp (TearLab) is an ophthalmic device company. It commercializes a proprietary in vitro diagnostic tear testing platform. The company's flagship TearLab osmolarity system measures the osmolarity of human tears to aid in the diagnosis of dry eye disease (DED) in patients. The company conducts it research and development activities through its wholly owned subsidiary, TearLab Research, Inc. The company sells its products directly in the US, Canada and the UK and through distributors in Europe, South America and Asia. TearLab is headquartered in San Diego, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

The report analyzes all pipeline products in development for the company TearLab Corp

The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

The report provides detailed description of products in development, technical specification and functions

The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

To formulate effective Research & Development strategies

Develop market entry and market expansion strategies

Exploit in licensing and out licensing opportunities by identifying products, most likely to ensure a robust return

Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage

Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

Identify, understand and capitalize the next high value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

TearLab Corp Company Overview 4

TearLab Corp Company Snapshot 4

TearLab Corp Pipeline Products and Ongoing Clinical Trials Overview 4

TearLab Corp Pipeline Analysis Overview 6

Business Description 6

TearLab Corp Key Facts 6

TearLab Corp Major Products and Services 7

TearLab Corp Pipeline Products by Development Stage 8

TearLab Corp Pipeline Products Overview 9

Multiplex Test Card 9

Multiplex Test Card Product Overview 9

Next Generation TearLab Osmolarity System 10

Next Generation TearLab Osmolarity System Product Overview 10

TearLab Discovery System 11

TearLab Discovery System Product Overview 11

TearLab Corp Key Competitors 12

TearLab Corp Key Employees 13

TearLab Corp Key Employee Biographies 14

TearLab Corp Locations And Subsidiaries 15

Head Office 15

Other Locations & Subsidiaries 15

Recent Developments 16

TearLab Corp, Recent Developments 16

May 10, 2018: TearLab Announces First Quarter 2018 Financial Results 16

Apr 11, 2018: TearLab Provides Update on 510(k) Filing for U.S. FDA Clearance of TearLab Discovery Platform 16

Mar 16, 2018: TearLab Announces Voluntary Delisting From Toronto Stock Exchange 16

Mar 02, 2018: TearLab Reports Fourth Quarter and Full Year 2017 Financial Results 17

Mar 01, 2018: European Union provides Biocartis with up to EUR 24m debt financing facility for infectious disease projects 17

Feb 28, 2018: TearLab Osmolarity System Launches in Brazil 18

Feb 16, 2018: Spanish center Santiago de Compostela joins the largest ever prospective study into familial risk of developing pancreatic cancer 18

Feb 14, 2018: TearLab Provides Update on i Pen Osmolarity System 19

Feb 14, 2018: TearLab Provides Update on TearLab Discovery Platform 19

Feb 13, 2018: Radiometer helps enhance patient outcomes at the University of Leicester Hospitals NHS Trust 19

Appendix 21

Methodology 21

About GlobalData 23

Contact Us 23

Disclaimer 24


List Of Figure

List of Figures

TearLab Corp Pipeline Products by Equipment Type 5

TearLab Corp Pipeline Products by Development Stage 8


List Of Table

List of Tables

TearLab Corp Pipeline Products and Ongoing Clinical Trials Overview 4

TearLab Corp Pipeline Products by Equipment Type 5

TearLab Corp Pipeline Products by Indication 5

TearLab Corp, Key Facts 6

TearLab Corp, Major Products and Services 7

TearLab Corp Number of Pipeline Products by Development Stage 8

TearLab Corp Pipeline Products Summary by Development Stage 8

Multiplex Test Card Product Status 9

Multiplex Test Card Product Description 9

Next Generation TearLab Osmolarity System Product Status 10

Next Generation TearLab Osmolarity System Product Description 10

TearLab Discovery System Product Status 11

TearLab Discovery System Product Description 11

TearLab Corp, Key Employees 13

TearLab Corp, Key Employee Biographies 14

TearLab Corp, Subsidiaries 15

Glossary 22

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

TearLab Corp,Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Companies

Advanced Tear Diagnostics, LLC

DiagnosTear Ltd.

LacriSciences, LLC

ReSearch Pharmaceutical Services Inc

TearScience Inc